Literature DB >> 6154014

Studies in immunodermatology. VIII. Immunofluorescence studies of stratum corneum antibodies.

W L Binder, E H Beutner, S Jablonska.   

Abstract

Stratum corneum antibodies (SCAb) as detected by indirect immunofluorescence (IIF) can be absorbed from human sera with homogenates of normal human callus which contain stratum corneum antigen. Titers of concomitantly present antibodies remain unchanged in sera absorbed with callus, thus showing that this absorption is specific. SCAb reacting in a passive hemagglutination assay with an antigen derived from human callus by means of a trypsin-phenol-water extraction can be specifically absorbed with the homologous antigen. However, absorption with callus fails to remove the hemagglutinating antibodies and absorption with the trypsin-phenol-water antigen preparation fails to remove SCAb detected by IIF. These data indicate a nonidentity relationship between these antigen systems despite their similar histological and anatomical tissue distribution. Reactivity of immunoglobulins and complement only with areas of traumatized stratum corneum in skin explants cultured on sera containing SCAb provide some insight as to a possible normal physiologic role for these ubiquitous complement-fixing autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154014

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  3 in total

1.  Non identity of non ionic detergent soluble (NIDS) protein and stratum corneum autoantigens.

Authors:  P J Dykes; D L Williams; R Marks
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

2.  Stratum corneum antibodies detected by hemagglutination are not directed against keratin intermediate filaments.

Authors:  S Qutaishat; V Kumar; E H Beutner; S Jabłońska
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Profile of anti-stratum corneum autoantibodies in psoriatic patients.

Authors:  H Tagami; K Iwatsuki; M Yamada
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.